End-to-End 3D Neural Screening Services with RealBrain® Technology
From Cells to Insight
Accelerate Preclinical Neuroscience Drug Discovery
Predictive. Scalable. Human-relevant.
RealBrain® offers ArtiBrain™ and ADBrain™ as validated 3D neural models. Flexible model development and assay development services allow researchers to design virtually any screen or analysis.
Our Services
-
Provides early safety data by detecting cytotoxicity, oxidative stress, and tissue integrity in a human-relevant 3D brain model.
-
Evaluates glial activation and biomarkers to identify neuroinflammatory responses that drive disease progression.
-
Delivers biomarker-driven insights into target engagement, synaptic health, and hallmark disease pathology.
-
Profiles mechanisms of neurodegeneration, with emphasis on neuronal cell death - ferroptosis and injury pathways.
-
Maps connectivity, branching, and synaptic changes to assess functional plasticity and network remodeling.
-
Bespoke 3D models and assays designed around your therapeutic targets and mechanisms.
Build Better Data with 3D Neural Tissues—Let’s Work Together
Ready to Start Your Study?
Let’s discuss how our end-to-end services can support your next compound screen, biomarker project, or preclinical program.